Schedule 13D ownership disclosure

Arcus Biosciences Inc

Security class unavailable · CUSIP: 03969F109

Event date: 2020-10-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,894,967
Percent of class
2.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-20-046531
Form type
SC 13D
Filer
Arcus Biosciences, Inc.
CIK
CIK 1724521
Filed
Oct 15, 2020
Reporting period
Oct 13, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub